Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 August 2023 | Story Rorisang Ramorena | Photo Supplied
Michael Skosana
Michael Skosana is set to leave on 30 August to start the semester on 1 September 2023 at the University of Applied Sciences in Austria.

Michael Skosana, a student on the Bloemfontein Campus of the University of the Free State (UFS), has been selected as the recipient of the 2023 Ernst Mach Grant scholarship exchange programme at the University of Applied Sciences in Austria.

Skosana, currently pursuing his honours in Financial Economics and Investment Management at the UFS, aspires to pursue not only his master's qualification but also his Chartered Financial Analyst (CFA) levels and regulatory exams and ultimately pass his board exams. Skosana is set to leave on 30 August to start the semester on 1 September 2023.

About the grant

The Ernst Mach Grant is a program aimed at students from non-European universities who wish to spend a semester or two at an Austrian University of applied sciences. The Austrian Ministry of Science and Research offers the Ernst Mach Grant to students with non-European citizenship who plan to take up exchanges at an Austrian university.

According to its 2023 – 2028 internationalisation strategy, the UFS aims to integrate international and intercultural dimensions into the university's being, including the formal and informal curriculum. The Office for International Affairs (OIA) enables such comprehensive internationalisation, and specifically its International Scholarships portfolio, under the leadership of Mbali Moiketsi, contributes by liaising with funding bodies for mobility, sharing information about possible opportunities, and supporting students through the process.

The responsibility of the OIA is to ensure that students and staff are exposed to intercultural opportunities as part of their learning curriculum through information sharing. The OIA partners and works with international funding agencies to bring the information to the students and staff and support them through the process.

Skosana's motivation to study abroad is to challenge himself on the spectrum of finance, to learn more about the Austrian and South African economies, and, hopefully, to work in Europe and gain insight before returning home to change the financial landscape of South Africa. He added that the acquired skills will empower and develop the South African financial economy and educate South Africans on financial literacy, investments, and any financial goals they seek knowledge about.”

Furthermore, Skosana encourages students to be more open to knowledge and international experiences by participating in such opportunities. He emphasizes that “students should always want to broaden their intercultural and global competencies beyond academics.”

For more information related to scholarships and opportunities, contact Mbali Moiketsi at the following email moiketsimv@ufs.ac.za

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept